Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 Healthcare Supply Chain Leadership Summit
    • 2024 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 Healthcare Supply Chain Leadership Summit
    • 2024 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Comments on FDA “Risk Management Plans to Mitigate the Potential for Drug Shortages” Draft Guidance

August 22, 2022 by Grace Crozier Federal Comments 0 comments

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the Food and Drug Administration’s (FDA) “Risk Management Plans to Mitigate the Potential for Drug Shortages” draft guidance.

Click here to read the full comments.

Prev
Next

Related Posts

HSCA Comments on FDA Draft Guidance for Drug Supply Chain Security Act (DSCSA) Standards
November 9, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Comments on FDA “Risk Management Plans to Mitigate the Potential for Drug Shortages” Draft Guidance
August 22, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Response to FDA Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Draft Guidance
June 5, 2023

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide
June 28, 2023

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
750 9th Street NW, Suite 650
Washington, DC 20001

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • Healthcare Supply Chain Leadership Summit Materials
    October 10, 2023
  • HSCA NAMES CHILDREN’S HOSPITAL ASSOCIATION VICE PRESIDENT OF PHARMACY TERRI LYLE WILSON TO BOARD OF DIRECTORS
    September 20, 2023